Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease
- DOI
- 10.1016/j.stem.2026.09.001
- Published
- 2026-09
- Container
- Cell Stem Cell
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.stem.2026.09.001,
title = {Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease},
author = {Denise Klatt and Adele Mucci and Boya Liu and Marie Peschers and Giulia Schiroli and Axel Schambach and John Manis and Myriam Armant and David T. Scadden and Els Verhoeyen and Danilo Pellin and David A. Williams and Christian Brendel},
year = {2026},
journal = {Cell Stem Cell},
doi = {10.1016/j.stem.2026.09.001},
url = {https://doi.org/10.1016/j.stem.2026.09.001}
}RIS
TY - JOUR TI - Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease AU - Denise Klatt AU - Adele Mucci AU - Boya Liu AU - Marie Peschers AU - Giulia Schiroli AU - Axel Schambach AU - John Manis AU - Myriam Armant AU - David T. Scadden AU - Els Verhoeyen AU - Danilo Pellin AU - David A. Williams AU - Christian Brendel PY - 2026 JO - Cell Stem Cell DO - 10.1016/j.stem.2026.09.001 UR - https://doi.org/10.1016/j.stem.2026.09.001 ER -
APA
Klatt, D., Mucci, A., Liu, B., Peschers, M., Schiroli, G., Schambach, A., Manis, J., Armant, M., Scadden, D. T., Verhoeyen, E., Pellin, D., Williams, D. A., & Brendel, C. (2026). Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.09.001
Source records
- crossref · retrieved 2026-09-25T08:29:11.229Z